KNG1 and diabetes mellitus: Moreover, the effects of diabetes on kininogen expression are in-line with our previous data where we found that the expression and activity of plasma prekallikrein (PK), the serine protease that cleaves kininogen to liberate the vasoactive peptide bradykinin, were elevated in T1DM patients.